Once Tako-tsubo syndrome is confirmed, it is reasonable to discontinue aspirin and continue beta blocker therapy due to the possible high catecholamine state and angiotensin-converting enzyme inhibitor (ACE-I)/angiotensin receptor blocker (ARB) therapy for regional wall motion abnormality treatment [4]. Here, ACE is linked to Tako-tsubo cardiomyopathy.